neutral rating,-0.419282
infectious disease,-0.603032
overweight rating,-0.419282
strong sell rating,0.641407
Inc.,0.466069
price objective,0.26784
RBC Capital,-0.210256
infectious diseases,-0.723845
hold rating,-0.205994
genetic disorders,-0.526641
InvestorPlace Broker Center,0.555736
1-year high,-0.50169
high fees,-0.735674
Janus Capital Management,0.0959537
biopharmaceutical company,0.41816
outperform rating,-0.210256
research report,0.28517
sell rating,0.564197
personal trading style,0.598412
PTC Therapeutics,-0.00875983
Jefferies Group,-0.491164
rare disorders,-0.553368
average rating,-0.427581
buy rating,0.319378
Parametrica Management,0.316547
JPMorgan Chase,-0.419282
shares,0.120608
small-molecule drugs,-0.526641
average target price,-0.427581
Jennison Associates,0.348185
sector perform rating,-0.210256
stock broker,0.245696
company,0.0827725
Saturday morning,0.28517
Verde Servico Internacionais,0.290531
research analyst,0.409776
underperform rating,-0.491164
new stake,0.318421
quarter,0.111642
